Sign In

Login

Password

Forgot Password ? Sign Up

Protrombinový čas (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Protrombinový čas" in Czech language version.

refsWebsite
Global rank Czech rank
7nih.gov
4th place
8th place
6doi.org
2nd place
4th place
5web.archive.org
1st place
1st place
1annals.org
low place
2,303rd place
1roche-diagnostics.cz
low place
low place

annals.org

  • Hirsh J, Bates SM. Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective. Ann. Intern. Med.. March 2001, roč. 134, čís. 5, s. 409–17. Dostupné online. PMID 11242501. 

doi.org

  • Horsti J, Uppa H, Vilpo JA. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents. Clin. Chem.. March 2005, roč. 51, čís. 3, s. 553–60. Dostupné v archivu pořízeném dne 2009-10-01. doi:10.1373/clinchem.2004.043836. PMID 15665046. 
  • Jackson CM, Esnouf MP. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?. Clin. Chem.. March 2005, roč. 51, čís. 3, s. 483–5. Dostupné v archivu pořízeném dne 2009-05-03. doi:10.1373/clinchem.2004.045393. PMID 15738512. 
  • Poller L, Keown M, Chauhan N, et al.. European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration. Br. J. Haematol.. September 2003, roč. 122, čís. 6, s. 944–9. doi:10.1046/j.1365-2141.2003.04521.x. PMID 12956765. 
  • Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. February 2006, roč. 367, čís. 9508, s. 404–11. doi:10.1016/S0140-6736(06)68139-7. PMID 16458764. 
  • Quick AJ, Stanley-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci. 1935, roč. 190, s. 501. doi:10.1097/00000441-193510000-00009. 
  • Owren PA, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. Clin. Lab. Invest.. 1951, roč. 3, čís. 3, s. 201–8. doi:10.3109/00365515109060600. PMID 14900966. 

nih.gov

ncbi.nlm.nih.gov

  • Della Valle P, Crippa L, Garlando AM, et al.. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica. December 1999, roč. 84, čís. 12, s. 1065–74. Dostupné v archivu pořízeném dne 2011-10-02. PMID 10586206.  Archivováno 2. 10. 2011 na Wayback Machine.
  • Horsti J, Uppa H, Vilpo JA. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents. Clin. Chem.. March 2005, roč. 51, čís. 3, s. 553–60. Dostupné v archivu pořízeném dne 2009-10-01. doi:10.1373/clinchem.2004.043836. PMID 15665046. 
  • Jackson CM, Esnouf MP. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?. Clin. Chem.. March 2005, roč. 51, čís. 3, s. 483–5. Dostupné v archivu pořízeném dne 2009-05-03. doi:10.1373/clinchem.2004.045393. PMID 15738512. 
  • Poller L, Keown M, Chauhan N, et al.. European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration. Br. J. Haematol.. September 2003, roč. 122, čís. 6, s. 944–9. doi:10.1046/j.1365-2141.2003.04521.x. PMID 12956765. 
  • Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. February 2006, roč. 367, čís. 9508, s. 404–11. doi:10.1016/S0140-6736(06)68139-7. PMID 16458764. 
  • Owren PA, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. Clin. Lab. Invest.. 1951, roč. 3, čís. 3, s. 201–8. doi:10.3109/00365515109060600. PMID 14900966. 
  • Hirsh J, Bates SM. Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective. Ann. Intern. Med.. March 2001, roč. 134, čís. 5, s. 409–17. Dostupné online. PMID 11242501. 

roche-diagnostics.cz

web.archive.org

  • Della Valle P, Crippa L, Garlando AM, et al.. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica. December 1999, roč. 84, čís. 12, s. 1065–74. Dostupné v archivu pořízeném dne 2011-10-02. PMID 10586206.  Archivováno 2. 10. 2011 na Wayback Machine.
  • Horsti J, Uppa H, Vilpo JA. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents. Clin. Chem.. March 2005, roč. 51, čís. 3, s. 553–60. Dostupné v archivu pořízeném dne 2009-10-01. doi:10.1373/clinchem.2004.043836. PMID 15665046. 
  • Jackson CM, Esnouf MP. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?. Clin. Chem.. March 2005, roč. 51, čís. 3, s. 483–5. Dostupné v archivu pořízeném dne 2009-05-03. doi:10.1373/clinchem.2004.045393. PMID 15738512. 
  • Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. International Journal of Cardiology. 10 March 2005. Dostupné v archivu pořízeném dne 2009-02-07. 
  • Roche diagnostics: CoaguChek - Otázky a odpovědi Archivováno 27. 9. 2013 na Wayback Machine. česky